Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma

Table 1 Baseline characteristics

Parameter	Number of participants (n = 66)
Mean age (yr)	53.3 ± 13.6
Sex
Male	55
Female	11
Maximum tumor diameter (cm)
≤ 5	27
5-10	26
> 10	13
Child-Pugh score
A	57
B7	9
BCLC stage
B	29
C	37
ECOG PS
0	46
1	20
Vascular invasion
Present	25
Absent	41
Portal vein invasion
Present	23
Absent	43
Extrahepatic metastasis
Present	16
Absent	50
HBV
Positive	54
Negative	12
HBV DNA (copies/mL)
> 2 × 103	30
≤ 2 × 103	36
Cirrhosis
Present	50
Absent	16
AFP (ng/mL)
≤ 100	26
> 100	40

AFP: Alpha-fetoprotein; HBV: Hepatitis B virus infection; BCLC: Barcelona Clinic Liver Cancer; ECOG PS: Eastern Cooperative Oncology Group performance status.